Archive | Transparency RSS feed for this section
Photo by Derek Gavey/ Flickr

Pharma companies in Slovakia: Uncovering conflicts of interest

Two years ago, the leading German pharmaceutical company, Boehringer Ingelheim, applied to Slovak authorities for its new anti-diabetes drug, Synjardy, to be covered by health insurance.  Drug manufacturers are keen for their medicine to be covered since it would reduce its price and therefore could sell more. Boehringer estimated in its application that within four […]

Read full story Comments { 0 }